(FM) Hematología

Departamento académico

Foto de (FM) Hematología

Foto de Fondazione IRCCS Istituto Nazionale dei Tumori

Fondazione IRCCS Istituto Nazionale dei Tumori

Milán, Italia

Publicaciones en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (6)

2023

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
eClinicalMedicine, Vol. 63

2021

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma
Investigational New Drugs, Vol. 39, Núm. 4, pp. 1028-1035

2020

Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: An analysis from the European Society for Blood and Marrow Transplantation
ESMO Open, Vol. 5, Núm. 5

2018

A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
Haematologica, Vol. 103, Núm. 8, pp. 1351-1358

2006

Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma
Cancer Research, Vol. 66, Núm. 4, pp. 2442-2450

2003

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
Blood, Vol. 102, Núm. 8, pp. 3043-3051